The CGM grey market: a reflection of global access inequity

Lancet Diabetes Endocrinol. 2019 Nov;7(11):823-825. doi: 10.1016/S2213-8587(19)30263-3. Epub 2019 Aug 16.

Authors

Oana Onisie¹, Hamish Crocket², Martin de Bock³

Affiliations

¹ Department of Paediatrics, University of Otago, Christchurch 8140, New Zealand.
² School of Health, Sport & Human Performance, University of Waikato, Hamilton, New Zealand.
³ Department of Paediatrics, University of Otago, Christchurch 8140, New Zealand; Department of Paediatrics, Canterbury District Health Board, Christchurch, New Zealand. Electronic address: martin.debock@otago.ac.nz.

PMID: 31427219
DOI: 10.1016/S2213-8587(19)30263-3

No abstract available

MeSH terms

Blood Glucose Self-Monitoring / economics*
Blood Glucose Self-Monitoring / ethics
Blood Glucose Self-Monitoring / instrumentation*
Costs and Cost Analysis
Diabetes Mellitus, Type 1 / blood
Diabetes Mellitus, Type 1 / therapy*
Healthcare Disparities / economics*
Humans
Insurance, Health
Marketing of Health Services
Morals